4/A

PRIMARY DOCUMENT

Company: IONIS PHARMACEUTICALS INC
Filed: April 17, 2020
Period of Report: April 15, 2020
Accession Number: 0000874015-20-000068

View Document ↗ View on SEC.gov ↗